CD13 as a potential theranostic target for prostate-specific membrane antigen-negative prostate cancer and first-in-human study of [18F]AlF-CD13-L1 PET/CT imaging.

Saved in:
Bibliographic Details
Title: CD13 as a potential theranostic target for prostate-specific membrane antigen-negative prostate cancer and first-in-human study of [18F]AlF-CD13-L1 PET/CT imaging.
Authors: Tang, Wei1 (AUTHOR), Zhou, Ming2 (AUTHOR), Lu, Chenxi2 (AUTHOR), Qi, Lin1 (AUTHOR), Zhang, Ye3 (AUTHOR), Tang, Yongxiang2 (AUTHOR) xyyf0401@qq.com, Gao, Xiaomei4 (AUTHOR) lswindy_2012@163.com, Hu, Shuo2,5 (AUTHOR) hushuo2018@163.com, Cai, Yi1 (AUTHOR) cai-yi@csu.edu.cn
Source: European Journal of Nuclear Medicine & Molecular Imaging. Jul2025, Vol. 52 Issue 8, p2826-2840. 15p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:16197070
DOI:10.1007/s00259-025-07140-2